Pei-li Wang
Beijing, 100091, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Critical pathways of traditional Chinese medicine and active ingredients for intervention in atherosclerosis: proliferation, migration, and phenotypic transformation of vascular smooth muscle cells
Journal: Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica
Published: January 09, 2026
Celastrol inhibits the DPYSL2-JAK/STAT pathway by targeting mito-IDHs mediated mitochondrial metabolism to exhaust breast cancer.
Journal: Acta pharmacologica Sinica
Published: September 25, 2024
Effectiveness and Safety of Qishen Yiqi Dripping Pill in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention: 3-Year Results from a Multicentre Cohort Study.
Journal: Chinese journal of integrative medicine
Published: March 11, 2024
Guanxin Danshen Dripping Pills Improve Quality of Life and Cardiovascular Prognoses of CHD Patients after PCI with Anxiety or Depression (GLAD Study): A Randomized Double-Blind Placebo-Controlled Study.
Journal: Chinese journal of integrative medicine
Published: July 22, 2022
Application Progress and Prospect of Herbal and Western Medicine Combined with Antiplatelet Therapy for Cardiovascular Events.
Journal: Evidence-based complementary and alternative medicine : eCAM
Published: February 08, 2021
Treatment of End-Stage Coronary Artery Disease with the Mode of Combination of Disease and Syndrome: A Case Report.
Journal: Chinese journal of integrative medicine
Published: June 20, 2020
The efficacy of Chinese herbal medicines on acute coronary syndrome with renal insufficiency after percutaneous coronary intervention.
Journal: Journal of ethnopharmacology
Published: April 30, 2019
Effect of Xinyue capsules on patients with coronary heart disease after percutaneous coronary intervention: study protocol for a randomized controlled trial.
Journal: Trials
Published: March 16, 2016
Long-term follow-up of Chinese herbal medicines combined with conventional treatment in patients with acute coronary syndrome after percutaneous coronary intervention: A multicenter randomized controlled trial.
Journal: Chinese journal of integrative medicine
Published: February 19, 2016
Resting heart rate associates with one-year risk of major adverse cardiovascular events in patients with acute coronary syndrome after percutaneous coronary intervention.
Journal: Experimental biology and medicine (Maywood, N.J.)
Published: August 07, 2015
Efficacy of Chinese Herbs for Supplementing Qi and Activating Blood Circulation on Patients with Acute Coronary Syndrome and Type 2 Diabetes Mellitus after Percutaneous Coronary Intervention: a Clinical Observation
Journal: Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine
Published: July 11, 2015
Chinese Herbal Medicines Might Improve the Long-Term Clinical Outcomes in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention: Results of a Decision-Analytic Markov Model.
Journal: Evidence-based complementary and alternative medicine : eCAM
Published: May 14, 2015
Last Updated: 09/26/2026